Friday 18 July 2014 10:30 – 12:00
Track 2 - Combination Medications as Novel Treatments for Stimulant Addiction (ASPET Symposium)
Chair: Leonard Howell
Relapse vulnerability phenotypes are suppressed by combined serotonin 5-HT2 receptor ligands
Kathryn Cunningham
Monoamines and Cocaine Medication Development in Nonhuman Primates
Leonard Howell
Human Laboratory Evaluation of Putative Combination Pharmacotherapies for Stimulant Use Disorders
William Stoops
Extended Release Mixed Amphetamine Salts and Topiramate for Cocaine Dependence: A Randomized, Double-Blin, Placebo-Controlled Trial
Frances Levin